Top Markets
Coin of the day
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rang in aandelen #33320
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Aandeelprijs
$0.26800822
Marktkapitalisatie
$7.89M
Verandering (1 dag)
5.56%
Verandering (1 jaar)
11.35%
Land
AU
Handel Cambium Bio Limited (CMB)

Categorie

Koersgeschiedenis voor Cambium Bio Limited (CMB)
Hoogste slotkoers: $0.27 op 2026-08-01

Laagste slotkoers: $0.27 op 2024-07-01
Koersgeschiedenis van Cambium Bio Limited van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -1.43%
2025 3.36%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE